22 Tex. Admin. Code § 291.29 - Professional Responsibility of Pharmacists
(a) A pharmacist shall exercise sound
professional judgment with respect to the accuracy and authenticity of any
prescription drug order dispensed. If the pharmacist questions the accuracy or
authenticity of a prescription drug order, the pharmacist shall verify the
order with the practitioner prior to dispensing.
(b) A pharmacist shall make every reasonable
effort to ensure that any prescription drug order, regardless of the means of
transmission, has been issued for a legitimate medical purpose by a
practitioner in the course of medical practice. A pharmacist shall not dispense
a prescription drug if the pharmacist knows or should have known that the order
for such drug was issued without a valid pre-existing patient-practitioner
relationship as defined by the Texas Medical Board in 22 Texas Administrative
Code (TAC) §190.8 (relating to Violation Guidelines) or without a valid
prescription drug order.
(1) A prescription
drug order may not be dispensed or delivered by means of the Internet unless
pursuant to a valid prescription that was issued for a legitimate medical
purpose in the course of medical practice by a practitioner, or practitioner
covering for another practitioner.
(2) A prescription drug order may not be
dispensed or delivered if the pharmacist has reason to suspect that the
prescription drug order may have been authorized in the absence of a valid
patient-practitioner relationship, or otherwise in violation of the
practitioner's standard of practice to include that the practitioner:
(A) did not establish a diagnosis through the
use of acceptable medical practices for the treatment of patient's
condition;
(B) prescribed
prescription drugs that were not necessary for the patient due to a lack of a
valid medical need or the lack of a therapeutic purpose for the prescription
drugs; or
(C) issued the
prescriptions outside the usual course of medical practice.
(3) Notwithstanding the provisions
of this subsection and as authorized by the Texas Medical Board in 22 TAC
§
190.8, a pharmacist may dispense a
prescription when a physician has not established a professional relationship
with a patient if the prescription is for medications for:
(A) sexually transmitted diseases for
partners of the physician's established patient; or
(B) a patient's family members if the patient
has an illness determined by the Centers for Disease Control and Prevention,
the World Health Organization, or the Governor's office to be
pandemic.
(c)
If a pharmacist has reasons to suspect that a prescription was authorized
solely based on the results of a questionnaire and/or in the absence of a
documented patient evaluation including a physical examination, the pharmacist
shall ascertain if that practitioner's standard of practice allows that
practitioner to authorize a prescription under such circumstances. Reasons to
suspect that a prescription may have been authorized in the absence of a valid
patient-practitioner relationship or in violation of the practitioner's
standard of practice include:
(1) the number
of prescriptions authorized on a daily basis by the practitioner;
(2) a disproportionate number of patients of
the practitioner receive controlled substances;
(3) the manner in which the prescriptions are
authorized by the practitioner or received by the pharmacy;
(4) the geographical distance between the
practitioner and the patient or between the pharmacy and the patient;
(5) knowledge by the pharmacist that the
prescription was issued solely based on answers to a questionnaire;
(6) knowledge by the pharmacist that the
pharmacy he/she works for directly or indirectly participates in or is
otherwise associated with an Internet site that markets prescription drugs to
the public without requiring the patient to provide a valid prescription order
from the patients practitioner; or
(7) knowledge by the pharmacist that the
patient has exhibited doctor-shopping or pharmacy-shopping
tendencies.
(d) A
pharmacist shall ensure that prescription drug orders for the treatment of
chronic pain have been issued in accordance with the guidelines set forth by
the Texas Medical Board in 22 TAC §
170.3(relating to Guidelines),
prior to dispensing or delivering such prescriptions.
(e) A prescription drug order may not be
dispensed or delivered if issued by a practitioner practicing at a pain
management clinic that is not in compliance with the rules of the Texas Medical
Board in 22 TAC §§
195.1-
195.4 (relating to Pain Management
Clinics). A prescription drug order from a practitioner practicing at a
certified pain management clinic is not automatically valid and does not negate
a pharmacist's responsibility to determine that the prescription is valid and
has been issued for a legitimate or appropriate medical purpose.
(f) A pharmacist shall not dispense a
prescription drug if the pharmacist knows or should know the prescription drug
order is fraudulent or forged. A pharmacist shall make every reasonable effort
to prevent inappropriate dispensing due to fraudulent, forged, invalid, or
medically inappropriate prescriptions in violation of a pharmacist's
corresponding responsibility. The following patterns (i.e., red flag factors)
are relevant to preventing the non-therapeutic dispensing of controlled
substances and shall be considered by evaluating the totality of the
circumstances rather than any single factor:
(1) the pharmacy dispenses a reasonably
discernible pattern of substantially identical prescriptions for the same
controlled substances, potentially paired with other drugs, for numerous
persons, indicating a lack of individual drug therapy in prescriptions issued
by the practitioner;
(2) the
pharmacy operates with a reasonably discernible pattern of overall low
prescription dispensing volume, maintaining relatively consistent 1:1 ratio of
controlled substances to dangerous drugs and/or over-the-counter products
dispensed as prescriptions;
(3)
prescriptions by a prescriber presented to the pharmacy are routinely for
controlled substances commonly known to be abused drugs, including opioids,
benzodiazepines, muscle relaxants, psychostimulants, and/or cough syrups
containing codeine, or any combination of these drugs;
(4) prescriptions for controlled substances
by a prescriber presented to the pharmacy contain nonspecific or no diagnoses,
or lack the intended use of the drug;
(5) prescriptions for controlled substances
are commonly for the highest strength of the drug and/or for large quantities
(e.g., monthly supply), indicating a lack of individual drug therapy in
prescriptions issued by the practitioner;
(6) dangerous drugs or over-the-counter
products (e.g., multi-vitamins or laxatives) are consistently added by the
prescriber to prescriptions for controlled substances presented to the
pharmacy, indicating a lack of individual drug therapy in prescriptions issued
by the practitioner;
(7) upon
contacting the practitioner's office regarding a controlled substance
prescription, the pharmacist is unable to engage in a discussion with the
actual prescribing practitioner; the practitioner fails to appropriately
address based on a reasonable pharmacist standard the pharmacist's concerns
regarding the practitioner's prescribing practices with regard to the
prescription; and/or the practitioner is unwilling to provide additional
information, such as treatment goals and/or prognosis with prescribed drug
therapy;
(8) the practitioner's
clinic is not registered as, and not exempted from registration as, a pain
management clinic by the Texas Medical Board, despite prescriptions by the
practitioner presented to the pharmacy indicating that the practitioner is
mostly prescribing opioids, benzodiazepines, barbiturates, or carisoprodol, but
not including suboxone, or any combination of these drugs;
(9) the controlled substance(s) or the
quantity of the controlled substance(s) prescribed are inconsistent with the
practitioner's area of medical practice;
(10) the Texas Prescription Monitoring
Program indicates the person presenting the prescriptions is obtaining similar
drugs from multiple practitioners, and/or that the persons is being dispensed
similar drugs at multiple pharmacies;
(11) multiple persons with the same address
present substantially similar controlled substance prescriptions from the same
practitioner;
(12) persons
consistently pay for controlled substance prescriptions with cash or cash
equivalents more often than through insurance;
(13) persons presenting controlled substance
prescriptions are doing so in such a manner that varies from the manner in
which persons routinely seek pharmacy services (e.g., persons arriving in the
same vehicle with prescriptions from same practitioner; one person seeking to
pick up prescriptions for multiple others; drugs referenced by street
names;
(14) the pharmacy charges
and persons are willing to pay significantly more for controlled substances
relative to nearby pharmacies;
(15)
the pharmacy routinely orders controlled substances from more than one drug
supplier;
(16) the pharmacy has
been discontinued by a drug supplier related to controlled substance
orders;
(17) the pharmacy has a
sporadic and inconsistent dispensing volume (including zero
dispensing);
(18) the pharmacy does
not maintain normal operational hours each week from Monday through Friday;
and
(19) the pharmacy has been
previously warned or disciplined by the Texas State Board of Pharmacy for
inappropriate dispensing of controlled substances.
(g) Prescriptions issued as a result of
telemedicine medical services or teledentistry dental services.
(1) The validity of a prescription issued as
a result of telemedicine medical services or teledentistry dental services is
determined by the same standards that would apply to the issuance of the
prescription in an in-person setting.
(2) A valid prescription issued as a result
of telemedicine medical services or teledentistry dental services must:
(A) be issued for a legitimate medical
purpose by a practitioner as part of a practitioner-patient relationship as set
out in Texas Occupations Code §
111.005;
and
(B) meet all other applicable
laws before prescribing, dispensing, delivering, or administering a dangerous
drug or controlled substance.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.